Entellus Medical Announces European Launch of XprESS(TM) LoProfile Multi-Sinus Dilation System

Loading...
Loading...
Entellus Medical, Inc.
ENTL
, a medical technology company focused on designing, developing and commercializing products for the minimally invasive treatment of chronic and recurrent sinusitis patients, today announced the European launch of the XprESS™ LoProfile Multi-Sinus Dilation System. The XprESS LoProfile product is used by ENT (Ear, Nose and Throat) physicians to open narrowed or obstructed sinus drainage pathways using balloon sinus dilation. Entellus will be exhibiting at the Congress of European ORL-HNS in Prague on June 7-11th. The Company will also be sponsoring a symposia led by Dr. David Roberts, Otorhinolaryngologist, Guy's University London entitled "Discussing Appropriate Intervention Strategies for Sinusitis." Dr. Peter Andrews, ENT Head and Neck Surgeon, The Royal National Throat, Nose and Ear Hospital and Royal Free Hospital, UK, with Dr. Paolo Castelnuovo, Professor of Otolaryngology, University of Insubria, Italy also participating. Entellus recently established its UK subsidiary and plans to sell its products using a combination of direct sales representatives and a network of independent distributors who have proven experience and expertise in selling products into the ENT markets of European countries. When used as a stand-alone therapy, Entellus Medical's balloon sinus dilation products are the only devices proven
See full press release
Market News and Data brought to you by Benzinga APIs
Posted In: NewsPress Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...